The 2022 World Health Organization (WHO) guidelines classify GH-secreting pituitary adenomas into densely granulated somatotroph tumors (DGSTs) and sparsely granulated somatotroph adenomas (SGSTs) based on GH immunoreactivity and cytokeratin patterns (8). The gene discussed is GH1; the disease is familial isolated pituitary adenoma.